TC-I 2014

CAS No. 1221349-53-6

TC-I 2014( —— )

Catalog No. M33511 CAS No. 1221349-53-6

TC-I 2014 shows antiallodynic properties in pain models.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 176 In Stock
5MG 273 In Stock
10MG 407 In Stock
25MG 631 In Stock
50MG 891 In Stock
100MG 1152 In Stock
500MG 2358 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TC-I 2014
  • Note
    Research use only, not for human use.
  • Brief Description
    TC-I 2014 shows antiallodynic properties in pain models.
  • Description
    TC-I 2014 (compound 5) is a potent and orally active Benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonist, with IC50 values of 0.8 nM, 3.0 nM and 4.4 nM for canine, human and rat channels respectively. TC-I 2014 exhibits antiallodynic properties in pain models.
  • In Vitro
    TC-I 2014 (compound 5) potently inhibits cold-induced TRPM8 currents in HEK293 cells stably expressing canine or human TRPM8, with IC50 values of 0.413 and 1 nM, respectively.
  • In Vivo
    TC-I 2014 (10 mg/kg, Orally once) completely prevents icilin-induced WDS.Animal Model:TC-I 2014 (10 mg/kg, Orally once) completely prevents icilin-induced WDS.Dosage:3, 5.6, 10 mg/kg.Administration:Orally once.Result:Produced greater than 90% inhibition at 3, 5.6, and 10 mg/kg administered 2 h prior to icilin challenge.
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    TRP/TRPV Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1221349-53-6
  • Formula Weight
    467.41
  • Molecular Formula
    C23H19F6N3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 250 mg/mL (534.86 mM; Ultrasonic )
  • SMILES
    FC(F)(F)c1ccccc1-c1cc(c2[nH]c(nc2c1)C1=NOC2(C1)CCCCC2)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Parks DJ, et Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists. J Med Chem. 2011 Jan 13;54(1):233-47.?
molnova catalog
related products
  • M-084 hydrochloride

    M-084 hydrochloride is a blocker of TRPC4/5 channel, with antidepressant and anxiolytic effects.

  • N-Ethyl-p-menthane-3...

    N-Ethyl-p-menthane-3-carboxamide is an agonist of TRPM8( EC50 : 3.7 μM).

  • RN-1747

    RN-1747 is a selective transient receptor potential cation channel subfamily V member 4 agonists (EC50: hTRPV4 of 0.77 μM, mTRPV4 of 4.0 μM, and rTRPV4 of 4.1 μM). RN-1747 also antagonizes TRPM8 (IC50: 4 μM).